The temozolomide RESCUE study: A phase II trial of continuous (28/28) dose-intense temozolomide (TMZ) after progression on conventional 5/28 day TMZ in patients with recurrent malignant glioma

被引：0
|
作者：
Perry, J. R.
Mason, W. P.
Belanger, K.
Kavan, P.
Fulton, D.
Easaw, J.
Kirby, S.
Macdonald, D.
Shields, C.
Pouliot, J.
机构：
[1] Sunnybrook Hlth Sci Ctr, Toronto, ON M4N 3M5, Canada
[2] Princess Margaret Hosp, Toronto, ON M4X 1K9, Canada
[3] Hop Notre Dame de Bon Secours, Montreal, PQ H2L 4K8, Canada
[4] Royal Victoria Hosp, Montreal, PQ H3A 1A1, Canada
[5] Cross Canc Inst, Edmonton, AB T6G 1Z2, Canada
[6] Tom Baker Canc Clin, Calgary, AB, Canada
[7] QE II Hlth Sci Ctr, Halifax, NS, Canada
[8] London Reg Canc Program, London, ON, Canada
[9] Hop Enfants Jesus, Quebec City, PQ, Canada
[10] Schering Plough Canada, Kirkland, PQ, Canada
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2008年 / 26卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2010
引用
收藏
页数：1
相关论文
共 25 条
  • [1] THE TEMOZOLOMIDE RESCUE STUDY: A PHASE II TRIAL OF CONTINUOUS (28/28) DOSE-INTENSE TEMOZOLOMIDE (TMZ) AFTER PROGRESSION ON CONVENTIONAL 5/28 DAY TMZ IN PATIENTS WITH RECURRENT MALIGNANT GLIOMA
    Perry, J.
    Mason, W.
    Belanger, K.
    Kavan, P.
    Fulton, D.
    Easaw, J.
    Kirby, S.
    Macdonald, D.
    Shields, C.
    Pouliot, J. F.
    NEURO-ONCOLOGY, 2008, 10 (06) : 1063 - 1063
  • [2] THE TEMOZOLOMIDE RESCUE STUDY: A PHASE II TRIAL OF CONTINUOUS (28/28) DOSE-INTENSE TEMOZOLOMIDE AFTER PROGRESSION ON CONVENTIONAL 5/28 DAY TEMOZOLOMIDE IN PATIENTS WITH RECURRENT MALIGNANT GLIOMA
    Mason, Warren
    Perry, James
    Belanger, K.
    Kavan, Petr
    Fulton, D.
    Easaw, Jacob
    Kirby, S.
    Macdonald, David
    Shields, C.
    Pouliot, J-F
    NEURO-ONCOLOGY, 2008, 10 (05) : 833 - 833
  • [3] Phase II Trial of Continuous Dose-Intense Temozolomide in Recurrent Malignant Glioma: RESCUE Study (vol 28, pg 2051, 2010)
    Perry, James R.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (21) : 3543 - 3543
  • [4] Phase II Trial of Continuous Dose-Intense Temozolomide in Recurrent Malignant Glioma: RESCUE Study
    Perry, James R.
    Belanger, Karl
    Mason, Warren P.
    Fulton, Dorcas
    Kavan, Petr
    Easaw, Jacob
    Shields, Claude
    Kirby, Sarah
    Macdonald, David R.
    Eisenstat, David D.
    Thiessen, Brian
    Forsyth, Peter
    Pouliot, Jean-Francois
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (12) : 2051 - 2057
  • [5] PHASE II TRIAL OF CONTINUOUS LOW-DOSE TEMOZOLOMIDE (TMZ) FOR PATIENTS WITH RECURRENT MALIGNANT GLIOMA (MG) WITH AND WITHOUT PRIOR EXPOSURE TO BEVACIZUMAB (REV)
    Khasraw, Mustafa
    Abrey, Lauren E.
    Lassman, Andrew B.
    Hormigo, Adilia
    Nolan, Craig
    Gavrilovic, Igor T.
    Mellinghoff, Ingo K.
    Reiner, Anne S.
    DeAngelis, Lisa
    Omuro, Antonio M.
    NEURO-ONCOLOGY, 2010, 12 : 72 - 72
  • [6] Phase II trial of continuous low-dose temozolomide (TMZ) for recurrent malignant glioma (MG) with and without prior exposure to bevacizumab (BEV)
    Khasraw, M.
    Abrey, L. E.
    Lassman, A. B.
    Hormigo, A.
    Nolan, C.
    Gavrilovic, I. T.
    Mellinghoff, I. K.
    Reiner, A. S.
    DeAngelis, L. M.
    Omuro, A. M.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [7] Phase II study of concurrent continuous Temozolomide (TMZ) and Tamoxifen (TMX) for recurrent malignant astrocytic gliomas
    Spence, AM
    Peterson, RA
    Scharnhorst, JD
    Silbergeld, DL
    Rostomily, RC
    JOURNAL OF NEURO-ONCOLOGY, 2004, 70 (01) : 91 - 95
  • [8] Phase II Study of Concurrent Continuous Temozolomide (TMZ) and Tamoxifen (TMX) for Recurrent Malignant Astrocytic Gliomas
    Alexander M. Spence
    Richard A. Peterson
    Jeffrey D. Scharnhorst
    Daniel L. Silbergeld
    Robert C. Rostomily
    Journal of Neuro-Oncology, 2004, 70 : 91 - 95
  • [9] Phase II trial of continuous low-dose temozolomide for patients with recurrent malignant glioma
    Omuro, Antonio
    Chan, Timothy A.
    Abrey, Lauren E.
    Khasraw, Mustafa
    Reiner, Anne S.
    Kaley, Thomas J.
    DeAngelis, Lisa M.
    Lassman, Andrew B.
    Nolan, Craig P.
    Gavrilovic, Igor T.
    Hormigo, Adilia
    Salvant, Cynthia
    Heguy, Adriana
    Kaufman, Andrew
    Huse, Jason T.
    Panageas, Katherine S.
    Hottinger, Andreas F.
    Mellinghoff, Ingo
    NEURO-ONCOLOGY, 2013, 15 (02) : 242 - 250
  • [10] PHASE II TRIAL OF CONTINUOUS LOW-DOSE TEMOZOLOMIDE FOR PATIENTS WITH RECURRENT MALIGNANT GLIOMA
    Ney, Douglas
    Deangelis, Lisa
    Nolan, Craig
    Gavrilovic, Igor
    Hormigo, Adilia
    Lassman, Andrew
    Abrey, Lauren
    NEURO-ONCOLOGY, 2008, 10 (05) : 831 - 831
123